RPS6KA3 and melanoma: Conversely, inhibition of RSKs or silencing of RSK1 and RSK2 in melanoma cells results in reduced mTORC1 activity and therefore, in decreased eIF4F activity, which correlates with reduced tumor growth in mice [25].